Tom Bulford examines five common mistakes that private investors make, and explains how you can avoid them.
Articles written by Tom Bulford
Bacteria are becoming increasingly resistant to antibiotics – the biotech firms developing alternatives are set to profit handsomely, says Tom Bulford.
Human body parts can now be ‘printed’ to replace defective ones. Tom Bulford looks at this exciting new technology, and focuses on one small-cap company making remarkable advances.
Stunning breakthroughs in biotechnology have changed the face of medicine forever. That’s opened plenty of opportunities for investors. Tom Bulford explains how you could profit.
This small-cap British firm is hoping to cash in on the growing success of K-pop, says Tom Bulford. So far it has hardly had the success of Gangnam Style. But could 2013 be its year?
This small-cap online marketing company has a simple idea and a stock market valuation of £20m. But can it and its investors make any money? Tom Bulford investigates.
As demand for diamonds increases, supply of the precious gems is unlikely to keep up. That suggests a very bright future for the diamond mining industry, says Tom Bulford.
Radical advances in biotechnology are ushering in what some are calling the ‘Third Revolution’. It could be one of the greatest investment stories of our time, says Tom Bulford.
This is a great time to be buying gold mining shares, says Tom Bulford. Here, he explains how to spot a potential winner, and picks four stocks to watch.
Extending Britain’s ‘health and safety’ culture into financial services will have entirely the opposite effect to the one intended, says Tom Bulford.